Preclinical and clinical data demonstrated that radiotherapy promoted T cell infiltration, increased the number of tumor infiltrating lymphocytes, expanded the T-cell receptor repertoire, and upregulated programmed cell death-ligand 1 (PD-L1) and major histocompatibility complex-I expression on tumor cells [17]. The gene discussed is CD274; the disease is neoplasm.